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The Role of Environmental Distractions in the Experience of 
Fibrofog in Real-World Settings
Anna L. Kratz,1  Daniel Whibley,2 Samsuk Kim,3 David A. Williams,1 Daniel J. Clauw,1 and Martin Sliwinski4
Objective. Perceived cognitive dysfunction in people with fibromyalgia (FM), “fibrofog,” is commonly reported 
and has been demonstrated in neurocognitive testing. Distractibility and inattention have been implicated as potential 
contributors to fibrofog, but the role of environmental distractions has not been explored. In this study, ambulatory 
assessment methods were used to examine whether FM is related to more environmental distractions and to examine 
the impact of distractions on subjective and objective cognitive functioning.
Methods. Fifty people with FM and 50 age-, sex-, and education-matched controls without FM completed 8 
consecutive days of ambulatory assessments. Five times per day, participants reported perceived cognitive 
functioning and environmental distractions and completed validated tests of processing speed and working memory.
Results. The FM group reported distractions in a higher proportion of the ambulatory cognitive testing sessions 
(40.5%) compared with the group without FM (29.8%; P < 0.001) and more often reported multiple simultaneous 
distractions. For both groups, sound was the most common distraction. The group with FM reported more distractions 
caused by light, and the group without FM reported more social distractions. Group differences in subjective and 
objective cognitive functioning were not augmented during distraction relative to during periods of no distraction. 
There were no group differences in within-person changes in cognitive functioning as a function of distraction.
Conclusion. The group with FM reported more distractions than the group without FM; both groups reported 
poorer processing speed when distracted, and the effects of distraction on test performance did not differ significantly 
by group. Findings suggest that sensitivity to environmental distractions may play a role in the experience of cognitive 
dysfunction in FM.
INTRODUCTION
Cognitive dysfunction is reported by approximately 70% of 
people with fibromyalgia (FM) (1-4) and is characterized by mem-
ory problems, inattention, learning difficulties, slow processing 
speed, and problems with executive functioning (3-10). These 
cognitive problems, collectively referred to as “fibrofog,” exert 
negative effects on perceptions about illness severity and over-
all mental health (5) and the ability to maintain a social network 
or employment and to perform a wide range of activities of daily 
life (6,11). Fibrofog is rated among the top five most troubling FM 
symptoms by clinicians and patients alike (12-14). Despite its high 
prevalence and serious impact, cognitive dysfunction in FM is not 
well understood; efforts to improve or compensate for cognitive 
dysfunction in FM rely on new insights into what factors and pro-
cesses contribute to fibrofog.
Distractibility and inattention have been strongly implicated 
as critical mechanisms underpinning fibrofog (9,10). Chronic pain, 
which is characteristic of FM, may consume attentional resources, 
and as such, may increase susceptibility to distraction (9-10,15-19). 
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Additionally, people with FM demonstrate increased sensitivity to a 
variety of environmental stimuli, consistent with a hypersensitivity 
to sensory stimuli (20,21), including temperature (22), sound (23-
25), visual stimuli (26), and olfactory stimuli (27,28).
A single laboratory-based study examined the role of dis-
traction on memory performance in people with or without FM 
(29). This study showed that when tested with no distraction 
during the encoding phase of a memory task, working memory 
ability in those with FM was largely intact; however, even a lim-
ited distraction interfered with memory recall ability in people with 
FM; compared with the control group, the group with FM lost 
44% more information (29). Although this single study has been 
held as evidence that distraction may be a critical factor underly-
ing fibrofog, the distraction paradigm of the study does not mimic 
real-world distractions. First, the distraction was constrained to 
the “encoding” period of the memory task, with no distraction 
during the stimulus/learning phase of the task; distractions in the 
real-world do not typically pause to allow one to attend to a task. 
Furthermore, the distraction in the study was a single cognitive 
task, whereas real-world experience may include sensory stimuli, 
interruptions from other people, etc, or a collection of multiple 
simultaneous distractions.
We have previously demonstrated in a sample of adults 
with FM and age-, sex-, and education-matched adults with-
out FM (non-FM) that people with FM demonstrate deficits in 
perceived cognitive function and objective working memory on 
ambulatory tests (30). As a follow-up to this primary article 
and to address limitations in our understanding of the role of 
environmental distractions in fibrofog in daily life, we will exam-
ine these ambulatory data to explore the role of environmental 
distractions in these FM-related deficits. We tested the fol-
lowing hypotheses: 1) the FM group will report environmental 
distractions more frequently during cognitive tests compared 
with the non-FM group; 2) relative to the non-FM group, the 
FM group will report a higher proportion of distractions caused 
by light, sound, and temperature; 3) group-level differences 
in aggregate/average subjective and objective cognitive func-
tioning will be greater for cognitive testing sessions in which 
distractions were endorsed; and 4) the FM group will show 
steeper momentary declines (compared with the non-FM 
group) in cognitive functioning when they report distraction 
relative to when they report no distraction.
PATIENTS AND METHODS
Participants. Participants were eligible if they were 1) 18 
years of age or older, 2) able to read at a sixth-grade level, and 
3) able to fluently converse in English. Exclusion criteria were the 
following: 1) comorbid neurological disorder (eg, stroke, demen-
tia, Parkinson disease, brain tumor, or moderate or severe trau-
matic brain injury), learning disorder, or cognitive impairment; 2) 
current substance (eg, alcohol, recreational drug) dependence or 
prolonged (5 years or longer) history of substance dependence; 3) 
visual or hearing impairment that would prevent standardized cog-
nitive testing; 4) diagnosis of untreated obstructive sleep apnea; 
and 5) atypical sleep/wake patterns (eg, night-shift work schedule). 
Participants in the FM group were required to meet the diagnostic 
criteria for FM according to the 2016 American College of Rheu-
matology (ACR) (31), whereas participants in the non-FM group 
were required not to meet the diagnostic criteria for FM accord-
ing to the 2016 ACR criteria. Each participant in the FM group 
was matched with a participant in the non-FM group based on 
sex, age, and education.
Study procedures. After the Medical Institutional Review 
Board at the University of Michigan approved all study procedures, 
participants were recruited through the University of Michigan from 
the surrounding community. Recruitment sources included exist-
ing participant registries, community groups, placement of  fliers in 
health centers and community settings, and advertisements of the 
study on a university-based recruitment website (www.UMHea 
lthre search.org). Data were collected between January 2018 and 
August 2018.
Participation in this study involved a 90-minute baseline 
visit, followed by an 8-day home-monitoring period. After initial 
screening over the telephone for study eligibility, participants 
were scheduled for an in-person visit, during which they under-
went informed consent procedures. During the baseline visit, 
participants also completed a battery of online self-report meas-
ures, completed in-person cognitive testing, and received 
instruction on how to use study-issued materials (wrist-worn 
accelerometer and smartphone). At the completion of data col-
lection, participants returned the study devices to the laboratory 
via a postage-paid return box for data download and processing. 
Participants were compensated up to $175 for full completion of 
the study.
SIGNIFICANCE & INNOVATIONS
• To our knowledge, this is the first study to explore 
the role of environmental distractions in the experi-
ence of fibrofog and cognitive performance in peo-
ple with fibromyalgia (FM) compared with people 
without FM.
• People with FM had similar declines in perceived 
and objective cognitive dysfunction when distract-
ed compared with those without FM.
• People with FM reported greater environmental 
distractions more frequently, despite being in a 
familiar (eg, home) environment more of the time, 
compared with those without FM.
• The role of environmental distraction in the experi-
ence of fibrofog warrants further examination.
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Data collection technology. Participants were provided 
a ZTE Axon 7 mini smartphone, which has a 5.2” display (1080 × 
1920 pixels) and no SIM card. This device was programmed with 
a customized study-specific app to administer ecological momen-
tary assessment (EMA) measures of subjective experiences and 
ambulatory cognitive tests. The smartphone was set up such that 
participants would initiate the first data collection session after 
waking. For the following four sessions, the app was programmed 
to play an audible alert to prompt the respondent to complete 
EMA and cognitive assessments. Alerts were programmed on 
a quasi-random schedule based on each participant’s typical 
waking time, with scheduled intervals between prompts ranging 
between 3 and 4.5 hours. Response data were stored onboard 
the smartphone. Data were downloaded and processed when the 
participant returned it to the laboratory.
Measures. Baseline self-report measures. Participants 
completed a self-report demographic questionnaire  assessing 
age, years of education, sex, and race/ethnicity, and a set 
of validated self-report surveys. Participants completed the 
Patient-Reported Outcome Measurement Information System 
(PROMIS) Pain Intensity 3a Short Form; participants rated worst 
and average pain in the past 7 days (on a 1 [no pain] to 5 [very 
severe] scale) and current level of pain (on a 1 [no pain] to 5 [very 
severe] scale), and item scores were summed and converted to 
a T-score metric with a mean of 50 and SD of 10. Higher scores 
on the short form indicate more severe pain. The Patient Health 
Questionnaire–8 (PHQ-8) (32) was used to assess the frequency 
of eight depressive symptoms in the past 2 weeks. Scores on 
the PHQ-8 range from 0 to 24, with higher scores indicating 
worse depressed mood. Fatigue was assessed with a four-item 
short form from the PROMIS fatigue item bank that reflected 
the experience of fatigue (33); scores are on a T-score metric 
with a mean of 50 and SD of 10. Higher scores indicate higher 
 fatigue.
EMAs. Perceived cognitive functioning was assessed us-
ing two items from the PROMIS Applied General Concerns (34) 
item bank. The items, adapted for momentary assessment, in-
clude the following: “How slow is your thinking right now?” (rat-
ed on a visual analog scale [VAS] of 0-100, in which 0 indicates 
“my thinking is very fast” and 100 indicates “my thinking is very 
slow”) and “How foggy is your thinking right now?” (rated on a 
VAS of 0-100, in which 0 indicates “my thinking is very clear” 
and 100 indicates “my thinking is very foggy”). The scores 
were averaged to produce an aggregate score, with higher 
scores indicating worse perceived cognitive functioning. The 
internal consistency for this scale in this study was Cronbach’s 
α = 0.95, indicating an excellent level of reliability.
On a dichotomous scale of “yes/no”, environmental distrac-
tions were assessed with the question, “During the brain games, 
were you distracted by anything in your environment?” If the par-
ticipant selected “yes,” the following checklist was provided with 
the instructions “please check all applicable distractions”: 1) dis-
tracting sounds, 2) distracting lights, 3) distracting temperature, 4) 
social distractions, and 5) other distraction.
Location during testing was assessed with the question, 
“Where are you?” Participants were provided with the following 
options to choose from: 1) inside my home, 2) inside at work, 3) 
outdoors, and 4) other.
Ambulatory cognitive tests. In addition to the EMAs men-
tioned above, two brief, valid, and reliable cognitive tests (35) 
were administered five times a day via a study-specific smart-
phone app. For both ambulatory cognitive tests, response times 
were recorded in milliseconds.
The symbol search task is a test of processing speed. During 
this task, participants saw a row of four symbol pairs at the top 
of the screen and two symbol pairs at the bottom of the screen 
and decided, as quickly as possible, which symbol pair at the bot-
tom matched one of the symbol pairs at the top and selected 
the matching pair by touching their selection at the bottom. Reac-
tion time and errors were recorded. Stimuli were presented until a 
response was provided. Sixteen trials were administered for each 
testing session. Three variables were calculated for trials: average 
(mean) reaction time per trial, median, and the SD (variability) in 
reaction time per trial.
The dot memory task is a test of working memory that con-
sists of three phases: encoding, distraction, and retrieval. During 
the encoding phase, the participant was asked to remember the 
location of three red dots appearing on a 5 × 5 square grid. After 
a 3-second examination period, the grid disappeared, and the 
distraction phase began. During the distraction phase, the partic-
ipant was asked to locate and touch all the F’s in an array of E’s. 
After the distraction task, the retrieval phase began by presenting 
an empty 5 × 5 square grid, and the participant was asked to 
place the red dots (by touching the empty squares) in the cor-
rect locations. Participants were asked to press “Done” when fin-
ished. Euclidean distance, a score of the collective distance of the 
three dots from their correct locations, was calculated. Four trials 
were administered for each testing session. Average Euclidean 
distance, maximum Euclidean distance, and the SD of Euclidean 
distances for each session were calculated for this task.
Data analysis. The sample was described according to 
age (mean, SD), proportion of female participants, number of 
years of education (mean, SD), and race/ethnicity. The first 
day of collection of ambulatory data was excluded from all 
analyses, allowing participants a practice day to familiarize 
themselves with the cognitive tests. The percentage of eligible 
cognitive tests that participants completed from day 2 onward 
was calculated, as were percentages of testing sessions 
during which participants endorsed being distracted. The 
percentage of total tests during which each group reported 
being distracted was compared using a two-sample test of 
proportions. The sum of the number of distractions endorsed 
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per testing session was calculated for each participant (eg, 
light and sound equaled two distractions), and distributions 
of these sums were plotted by group and compared using 
a χ2 test. Because of the small number of observations for 
which participants reported four or five distractions during a 
testing session, these categories were combined. The phys-
ical locations of participants during testing sessions in which 
they reported being distracted were summarized (number and 
proportion, by group) and compared using a χ2 test. The num-
ber and proportion of distractions by qualitative type was also 
summarized, with percentages per group compared using 
two-sample tests of proportions.
Linear regression was used to investigate group-level 
differences in subjective and objective cognitive functioning 
as a function of distraction status, with models predicting 
the aggregate mean value of the outcome by distraction sta-
tus, including a group-by-distraction status interaction term. 
Unadjusted analyses were conducted in the first instance, 
followed by models adjusted for baseline pain (PROMIS 
pain intensity T-score), fatigue (PROMIS fatigue experience 
T-score), and depression severity (PHQ-8). Seven cogni-
tive outcome variables were assessed in separate analy-
ses: self-reported cognitive function, three symbol search 
task variables (response time mean, median, and SD), and 
three dot memory task variables (mean error, maximum 
error, and SD of Euclidean distance errors). To determine 
whether momentary associations between cognitive function 
and distraction status were moderated by group member-
ship, multilevel level models were used (cognitive reports and 
contemporaneous distraction status nested within partici-
pants) that included a group-by-distraction status interaction 
term. Models were adjusted for age, sex, and years of edu-
cation. For the six objective outcome variables, adjustments 
were also made for the number of times the participant had 
completed the cognitive task to correct for possible improve-
ments in performance caused by practice effects. Analyses 
were performed using Stata (version 15; StataCorp), with a 
P value of less than 0.05 used as the threshold to determine 
statistical significance.
RESULTS
Descriptive statistics. One hundred participants (50 
with FM and 50 without FM) were eligible, provided informed 
consent, and completed baseline and repeated-measures 
assessments. The sample was mostly female and white, 
with an average age of 45 years (Table  1). The groups dif-
fered significantly in terms of mean PROMIS pain intensity 
T-scores (F98 = 14.52, P < 0.001; meanFM = 54.33, SD = 6.12, 
range = 44-72; meannon-FM = 35.55, SD = 6.81, range = 31-58). 
Participants were compliant with the data collection proce-
dures, completing an average of 90.9% of all possible cogni-
tive testing sessions; the FM group had, on average, 91.2% 
complete data, and the non-FM group had 90.5% complete 
data. Although participants were instructed to complete the 
ambulatory assessments for 8 consecutive days, some partic-
ipants completed a few additional assessments (eg, kept the 
phone through the morning of the ninth day). All available data 
were examined in these analyses. As a result, there were very 
small differences in the number of cognitive testing sessions 
administered to the two groups because of minor variations in 
the number of days/sessions for which the participants pro-
vided data.
Between-group comparison of environmental dis-
tractions during cognitive tests. Of 1654 cognitive testing 
sessions, the FM group provided distraction ratings for 1633 
(98.7%). Of 1629 cognitive testing sessions, the non-FM group 
provided distraction ratings for 1617 (99.2%). The FM group 
reported being distracted during 40.5% of these sessions 
(n = 661), whereas the non-FM group reported being distracted 
for 29.8% of these sessions (n = 481), a statistically significant dif-
ference (mean difference: 10.7% [95% confidence interval 7.5%-
14.0%]; SE = 0.02; z = 6.41; P < 0.001).
Within the 661 distracted sessions for the FM group, a total 
of 1117 distraction sources were endorsed. Within the 481 dis-
tracted sessions for the non-FM group, a total of 724 distraction 
sources were endorsed. There was a statistically significant rela-
tionship between the sum of distractions per distracted testing 
Table 1. Participant demographic characteristics
 
Total Participants 
(N = 100)
Participants With FM 
(n = 50)
Participants Without 
FM (n = 50)
Age, y    
Mean (SD) 45.1 (13.9) 44.9 (13.9) 45.2 (14.0)
Range 18-73 20-70 18-73
Female sex, n (%) 88 (88) 44 (88) 44 (88)
Education, y, mean (SD) 15.7 (2.0) 15.7 (2.0) 15.8 (2.0)
Race, n (%)    
White 81 (81) 43 (86) 38 (76)
Black 13 (13) 5 (10) 8 (16)
Biracial or multiracial 3 (3) 2 (4) 1 (2)
Asian 3 (3) 0 (0) 3 (6)
Abbreviation: FM, fibromyalgia.
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session and group membership, with the FM group reporting a 
significantly higher number of sources of distraction per session 
(χ2 = 24.7; P < 0.001) (Figure 1). For example, across the dis-
tracted sessions, the FM group reported two distractions 31.5% 
of the time and three distractions 13.2% of the time. In contrast, 
the non-FM group reported two distractions 22.9% of the time 
and three distractions 7.7% of the time during distracted sessions.
Physical location during distracted tests. The FM 
group was more frequently at home and less frequently outdoors 
during distracted sessions compared with the non-FM group 
(Table 2). Results of a χ2 test indicated a statistically significant 
relationship between location when distracted and group mem-
bership (χ2 = 10.00; P = 0.02).
Proportion of distraction type by group. The most 
common source of distraction reported during cognitive tests by 
both groups was sound. The FM group reported statistically signif-
icant higher proportions of distractions due to light and other dis-
tractions, whereas the non-FM group was more likely to endorse 
social distractions (Table 3).
Group-level differences in subjective and objective 
cognitive functioning as a function of distraction. There 
were no significant interactions between group membership and 
distraction status for subjective or objective measures of cognitive 
function (all P > 0.70). This finding was consistent after adjust-
ing for baseline levels of pain intensity, fatigue, and depression (all 
P > 0.66).
Group differences in momentary changes in subjec-
tive and objective cognitive functioning as a function 
of distraction. Multilevel model results indicated a significant 
group-by-distraction status interaction for subjective cogni-
tive functioning (B = −2.22; SE = 0.99; z = −2.24; P = 0.025), 
whereas momentary distraction status was not associated with 
concurrent self-reported cognitive function for the FM group (con-
trast test −0.01; SE = 0.72; z = −0.01; P = 0.99); for the non-FM 
group, being distracted was associated with slightly better self- 
reported cognitive function (contrast test −2.23; SE = 0.66; 
z = −3.37; P = 0.001). Although statistically significant, the effect 
was modest. There were no significant interactions between 
group membership and distraction status for any momen-
tary measures of objective cognitive function (all P < 0.34).
There were main effects of distraction on objective cognitive 
function. In multilevel models predicting cognitive test performance 
from distraction status, controlling for group and pre-stated covar-
iates, there were significant main effects for poorer mean reaction 
time SD (B = 108.80; SE = 26.76; z = 4.07; P < 0.001), mean 
error (B = 0.30; SE = 0.05; z = 6.53; P < 0.001), maximum 
error (B = 0.43; SE = 0.08; z = 5.58; P < 0.001), and error SD 
(B = 0.11; SE = 0.04; z = 3.00; P = 0.003) during distracted 
Figure 1. Histograms of the percentage of testing sessions in which distractions were endorsed with 1, 2, 3, or 4 to 5 total concurrent 
distractions for the group with fibromyalgia (FM) (n = 661 distracted sessions) and the group without fibromyalgia (non-FM) (n = 481 distracted 
sessions).
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Table 2. Frequency of distracted sessions by location and group
Location FM Non-FM Total
At home 422 (63.8%) 283 (58.8%) 705
At work 84 (12.7%) 56 (11.6%) 140
Outdoors 43 (6.5%) 56 (11.6%) 99
Other 112 (16.9%) 86 (17.9%) 198
Total 661 481 1142
Abbreviation: FM, fibromyalgia.
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sessions relative to nondistracted session. There were no main 
effects of distraction on tests of working memory.
DISCUSSION
One prevailing hypothesis about mechanisms underlying 
fibrofog is that increased sensitivity to external distractions, such 
as light and sound, is an important contributor to difficulty attend-
ing to cognitive tasks for people with FM (9,21). This is the first 
study to examine the experience of environmental distractions 
during cognitive work in the lived-in environment, comparing 
people with and without FM. People with FM reported more dis-
tractions more frequently compared with those without FM; this 
includes more frequent reporting of multiple simultaneous dis-
tractions. This set of findings is consistent with the expectation 
that people with FM will perceive more distractions in the lived-in 
environment because of perceptual amplification and generalized 
hypersensitivity to both internal and external stimuli (21).
This increase in the frequency of perceived distractions was 
paired with an expected decrease in cognitive performance—
specifically, processing speed—in the context of distractions. The 
expectation that those with FM would demonstrate a more robust 
decline in cognitive performance and in perceived cognitive func-
tioning in the context of distractions compared with those with-
out FM was not supported. Both groups demonstrated decline 
in cognitive performance on ambulatory tests during distractions 
and were not different in the scope of this decline. This is in conflict 
with evidence from existing literature showing that individuals with 
FM tend to have particular difficulty minimizing the co-occurrence 
or consequences of distractions from stimulus competition, which 
has led to decreased working memory and processing informa-
tion and impaired executive functioning (7-8,10,29). Brain imaging 
studies suggest that the decreased task-related brain activity in 
people with FM represents a deficit in the inhibition network and 
increased activation in other brain regions, which suggests com-
peting resources resulting in reduced resources for staying atten-
tive and performing tasks (19). The reduced attentional resources 
can lead to greater susceptibility to distraction and slow informa-
tion processing (10). This initial conflicting finding that people with 
FM are not especially susceptible to cognitive effects of distrac-
tion warrants replication and extension in studies that are more 
sophisticated in terms of how distractions and cognition are 
assessed in real-world settings. Future studies that pair ambula-
tory assessment of cognition with neuroimaging techniques could 
provide new insights into how brain function/connectivity relate to 
day-to-day distractibility and fibrofog.
Interestingly, and in contrast with expectations, ratings of 
perceived cognitive dysfunction did not differ based on distrac-
tion status for those with FM and were lower during distracted 
sessions for those without FM. The EMA items of perceived 
cognitive dysfunction assessed mental clarity and speed; it is 
possible that when people without FM reported low levels of 
cognitive dysfunction, they were signaling a sense of alertness 
or awareness that made them more perceptive of environmental 
distractions.
These findings reveal a number of interesting contextual 
details about distractions and cognition in FM. The finding 
that people with FM report more environmental distractions is 
particularly striking given that they were more likely than those 
without FM to report being distracted while at home and less 
likely to be distracted while outdoors. This makes sense in 
the context of findings that chronic pain, including FM-related 
pain, contributes to disability, isolation, and social withdrawal 
(36,37). This study did not track participants’ locations, so it 
is not possible to know why individuals with FM were more 
likely to report distractions in a familiar environment (home) and 
less likely to report distractions outdoors; this finding warrants 
further examination. Although sound was the most common 
source of distraction for both groups, it is notable that people 
with FM were more likely to report distractions from light; again, 
this is interesting in the context of these distractions occurring 
in the home rather than outdoors, as was more common in the 
non-FM group.
The focus of this article was on the role of distractions per-
ceived in the external environment. People with FM may also 
be subject to more internal distractions or interference from 
sensory and emotional experiences, such as pain, fatigue, and 
depressed mood, and the influence of these internal expe-
riences on fibrofog is the focus of a separate analysis of these 
data. However, a broader range of potentially impactful factors, 
such as FM-related alterations in brain structure and function (eg, 
gray matter volume and neuroinflammation) needs to be exam-
ined to fully understand the underlying mechanisms of cognitive 
dysfunction in FM and to identify potentially fruitful preventive, 
Table 3. No. and percentage of distractions by type
Distraction Source FM, n (%) Non-FM, n (%)
Two-Sample Test 
of Proportions, P
Light 70 (6.3) 27 (3.7) 0.003
Temperature 63 (5.6) 39 (5.4) 0.41
Social 270 (24.2) 236 (32.6) 0.006
Sound 431 (38.6) 295 (40.7) 0.18
Other 283 (25.3) 127 (17.5) <0.001
Total 1117 (100) 724 (100) …
Abbreviation: FM, fibromyalgia.
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restorative, and compensatory strategies to address fibrofog. 
Comparisons of common and distinct mechanisms of cognitive 
dysfunction across different conditions associated with cognitive 
difficulties (eg, cancer treated with chemotherapy, clinical depres-
sion) are also likely to increase our understanding of poor cognitive 
functioning in people with FM.
This article provides an important first look at the role of 
environmental distractions in fibrofog in the daily lives of people 
with FM; however, the findings must be interpreted in the context 
of a number of limitations. Effort on the cognitive tests was not 
assessed using traditional tests of motivation; however, as noted 
in the primary article, high accuracy on the processing speed 
test and lack of global deficits on ambulatory tests (30) does not 
support the notion that the people with FM were “faking bad” or 
demonstrating poor effort relative to the controls without FM. The 
study relied solely on self-report of distractions, which does not 
capture objective levels of environmental stimulation. Future stud-
ies would ideally incorporate continuous passive measurement of 
ambient temperature, noise, light, etc to objectively assess the 
environment. Future studies could also incorporate experimen-
tally administered distractions, such as lights and sounds from 
the testing device, for some of the test sessions. Collection of 
objective data on environmental distractions as well as adminis-
tration of experimentally induced distractions would also provide 
the opportunity to examine the psychometrics of the ambulatory 
self-reported distractions measures, which is sorely needed. 
Another limitation is that the two cognitive tests assessed a very 
limited range of cognitive functioning domains; higher-level cog-
nitive domains, such as aspects of executive functioning and 
cognitive flexibility, might be more sensitive to the effects of dis-
traction than the tests of processing speed and working memory, 
which are relatively lower-level cognitive domains. Future studies 
in larger samples that include other non-FM populations with 
chronic pain (such as those with arthritis or headache) or peo-
ple with sensory sensitivity but without chronic pain would pro-
vide additional insights into the mechanisms underlying brain fog 
including fibrofog.
Despite similar declines in objective cognitive functioning 
when distracted, relative to those without FM, evidence from this 
study suggests that people with FM do experience more distrac-
tions more often in their environment. Findings support the idea 
that sensitivity to environmental stimulation may play a role in the 
cognitive problems in everyday life for those with FM.
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